Algert Global’s DICE Therapeutics, Inc. Common Stock DICE Stock Holding History

Algert Global’s Portfolio DICE Stock Details DICE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q3	–	Sell	-12,300	Closed	-$571K	–	1301
2023 Q2	$571K	Buy	+12,300	New	+$425K	0.02%	790

Algert Global's DICE Position: Q3 2023 in Review

Algert Global sold out of DICE Therapeutics, Inc. Common Stock (DICE) in Q3 2023, closing a stake of 12,300 shares — an estimated $571K sold.

Algert Global first reported a position in DICE in Q2 2023 and held it in 1 quarter. The position peaked at $571K in Q2 2023. 0 funds tracked by Wall St. Rank hold DICE as of Q3 2023.

Algert Global reported no remaining DICE Therapeutics, Inc. Common Stock position as of Q3 2023 after selling out during the quarter.
Algert Global sold 12,300 DICE Therapeutics, Inc. Common Stock shares in Q3 2023, an estimated $571K.
Algert Global first reported a position in DICE Therapeutics, Inc. Common Stock in Q2 2023 and held it in 1 quarter.
Algert Global's DICE Therapeutics, Inc. Common Stock position peaked at $571K in Q2 2023.
0 funds tracked by Wall St. Rank held DICE Therapeutics, Inc. Common Stock as of Q3 2023.

Based on Algert Global's 13F filing for Q3 2023, filed 13 Nov 2023.